I'm co-founder and CEO/CSO of Genel, a biotechnology company providing innovative solutions to enhance drug development and reduce the time-to-market of new drugs.
Genel proposes a translational approach to screen multicellular tumor spheroid models and primary cells. Our innovative methodology combines bioscreening, microfluidics, image analysis and bioinformatics to guarantee an effective, fast, and innovative drug development process.
Our unique know-how allows us to offer an innovative high content and functional screening using active compounds: small molecules, siRNA, miRNA, active ingredients...
You'll find more information on our website www.genel.fr
If you have further questions, do not hesitate to contact me, I would be pleased to answer them.
Mes compétences :